| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
1e-13 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-09 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
9e-05 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-05 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
Nutlin-3 |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0001 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0002 |
| mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |